MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Duodenal levodopa infusion: Safety and efficacy in a 6 years outpatient follow-up

    S. Simoni, N. Tambasco, E. Sacchini, P. Nigro, F. Ripandelli, P. Calabresi (Perugia, Italy)

    Objective: To reduce the risk of adverse events and dropout rate in patients. Background: Duodenal levodopa infusion (DLI) is used for the treatment of advanced…
  • 2016 International Congress

    Patient experiences following Parkinson’s disease treatment with inhaled levodopa: Results from a Phase 2b study

    P. LeWitt, A. Niyazov, A. Sedkov, H. Murck, A. Guo (West Bloomfield, MI, USA)

    Objective: To report patient experiences from a clinical trial investigating Parkinson's disease (PD) control following treatment with inhaled levodopa. Background: CVT-301, an inhaled levodopa powder…
  • 2016 International Congress

    A survey of impulse control disorders in Chinese patients with Parkinson’s disease and literature review

    Q. Xiao, X. Wang, Y. Tan, M. Wei (Shanghai, People's Republic of China)

    Objective: This study aims to investigate the incidence of ICD in Chinese PD patients from Shanghai area, explore the association of ICD with dopamine replacement…
  • 2016 International Congress

    Utilizing remote blood pressure monitoring in a phase III clinical drug trial for Parkinson’s disease

    J.L. Adams, R.A. Biemiller, K.L. Andrzejewski, S. Sharma, R.L. Rockhill, B.L. Greco, K.C. Hodgeman, P. Singh, S. Khanuja, T. Simuni, K.M. Biglan (Rochester, NY, USA)

    Objective: To determine the feasibility and value of remote blood pressure (BP) monitoring during a clinical trial of isradipine (a dihydropyridine calcium channel antagonist) in…
  • 2016 International Congress

    Regional differences in the results of a phase 2b study of tozadenant in Parkinson’s disease patients with motor fluctuations

    C. Kenney, K. Kieburtz, W. Olanow, S. Bandak (San Francisco, CA, USA)

    Objective: To assess how the efficacy of tozadenant differed by region in a randomized, double-blind, placebo-controlled trial of Parkinson's disease patients with motor fluctuations. Background:…
  • 2016 International Congress

    The study of clinical outcome of deep brain stimulation for the idiopathic Parkinson’s disease at 6 months follow-up

    P. Papitak, M. Aphiwatthanakun, T. Srikijvilaikul, N. Limotai (Bangkok, Thailand)

    Objective: The aim of this study was to assess the motor and psychiatric outcomes at 6 months after subthalamic nucleus deep brain stimulation (STN-DBS) in…
  • 2016 International Congress

    Difference between physiologically defined subthalamic nucleus target and final lead placement: Influence in clinical outcome

    A. Medina, D. Cerquetti, M. Merello (Buenos Aires, Argentina)

    Objective: To evaluate distance between the physiologically defined subthalamic nucleus (STN) target and final lead placement, and its influence on the clinical outcome at 6…
  • 2016 International Congress

    Successful DBS: Doctors happy, patients not – Why?

    M.H. Strothjohann, B. Holzinger, G.A. Fuchs, F. Weber (Bad Camberg, Germany)

    Objective: Deep brain stimulation (DBS) in Parkinson's disease (PD) has been proven successful; however, not in all. Background: We report on 5 PD patients who…
  • 2016 International Congress

    Comparison of four DBS lead designs under voltage and current operating modes based on patient specific simulations

    F. Alonso, N. Göransson, P. Zsgimond, K. Wårdell (Linköping, Sweden)

    Objective: To quantitatively compare the spatial extension of the electric field generated by four different lead designs operated under voltage and current modes. Background: Conventional…
  • 2016 International Congress

    A prospective study of patients’ expectations in subthalamic nucleus deep brain stimulation for Parkinson’s disease

    N.R. Mundil, H.Y. Ling, H. Hasegawa, M. Samuel, K. Ashkan (London, United Kingdom)

    Objective: To prospectively assess the long-term outcome of subthalamic nucleus (STN) deep brain stimulation (DBS) and the relationship with patients' expectations and satisfaction. Background: Subthalamic…
  • 1
  • 2
  • 3
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #25676 (not found)
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • #24376 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • A Case of Pregabalin induced Parkinsonism
  • A survey-based analysis of abnormal movements in patients with Postural Tachycardia Syndrome (PoTS)
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley